Search - tctmd.com

Displaying 121 - 140 of 145

Sort: Relevancy | Date

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Daily News

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

Todd Neale

October 08, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

News Daily News

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

Jason Kahn

April 03, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

Advertisement

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Nationwide Registry Shows Trends in DES Use Over a Decade

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

DES Outcomes Vary by Diabetes Status, Lesion Complexity

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content